Cefprozil

Cefprozil

Clinical data
Pregnancy category	Category-B
Routes of administration	ORAL
ATC code	J01DC10 (WHO)
Pharmacokinetic data
Bioavailability	95%
Protein binding	36%
Elimination half-life	1.3 hours
Identifiers
IUPAC name 7-[2-amino-2-(4-hydroxyphenyl)-acetyl]amino-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	92665-29-7
PubChem CID	9887643
DrugBank	APRD00461
ChemSpider	8063315
UNII	1M698F4H4E
CompTox Dashboard (EPA)	DTXSID10873545
Chemical and physical data
Formula	C18H19N3O5S
Molar mass	389.427 g/mol g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C2N1/C(=C(/C=C/C)CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccc(O)cc3)N)C(=O)O.O
(verify)

Cefprozil, sometimes spelled cefproxil and sold under the brand name Cefzil, is a second-generation cephalosporin type antibiotic. In Europe, it is sold by the name Procef and Cronocef. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice (February 2006) has shown no increased risk for cross-allergy for cefprozil and several other 2nd generation or later cephalosporins.

External links

• Information about Cefprozil